Skip to main content

Table 1 Demographic data of the M.S patients and healthy controls:

From: The significance of miRNA-191-5P and miRNA-24-3P as novel biomarkers for multiple sclerosis: a case–control study

Clinical data

All MS (n = 80)

RRMS (n = 68)

Progressive MS (n = 12)

Healthy control (n = 40)

Age (years)

Mean ± SD

32 ± 7.9

31.6 ± 8

34.5 ± 7

30.4 ± 8.2

Gender No, (%)

Female

66 (82.5%)

59 (86.7%)

7 (58.3%)

33 (82.5%)

 

Male

14 (17.5%)

9 (13.2%)

5 (41.6%)

7 (17.5%)

  1. Age (years) is represented as Mean±SD
  2. Gender is represented as number and percent